Experience translates into Value

What does it take to built a synthetic biology company, or develop the next breakthrough industrial enzyme or biomaterial in todays AI-driven world? What questions should investors be asking and what sectors show the most promise? How can Government agencies craft policy that best suits the growth of strategically important biomanufacturing capabilities?

The best way to address these questions is to talk to people who have worked in this industry for decades and have developed and commercialized products across several sectors. Engineering biology remains an extraordinary complex endeavor and AI-driven insight is only as good as the data it is trained on. Work with an experienced scientist and R&D leader who understands the connection between strategic ambition and practical execution as we build the bioeconomy together.